IntegenX Inc., the leading developer of rapid human DNA identification technology, DNA sequencing library preparation systems, and DNA/RNA room temperature stability and storage products, today announced the appointment of Bob Barrett as Vice President of Strategy and Business Development for Human Identity Products (HID). Mr. Barrett will drive the strategy for introducing the RapidHIT™ 200 sample-to-profile HID system, and will develop the business relationships and plans for follow-on HID products.

Mr. Barrett has more than 25 years experience leading the successful commercialization of valuable novel products for diagnostics, biotechnology, and applied markets in the life sciences. His knowledge and expertise in applied markets and HID technologies is expected to accelerate the growth and widespread expansion of IntegenX HID solutions in defense, law enforcement, and applied markets. He has held senior executive positions at leading companies, most recently as Vice President of Global Marketing Molecular Diagnostics at QIAGEN. Prior to QIAGEN, Mr. Barrett was Vice President/General Manager of the Applied Markets Division at Applied Biosystems, where he played a key role in the development of the HID business. He also served as Vice President of Global Marketing at Roche Molecular Systems and as Vice President of Commercial Operations (Diagnostics) at Chiron Corporation.

“Recruiting a proven leader boosts our depth and breadth of talent to capture the emerging rapid HID market and to drive IntegenX technologies into new markets. Bob has a keen ability to identify, select, and develop strategies for the HID and applied markets as well as build teams to execute those plans,” said Dr. Stevan Jovanovich, Chief Executive Officer of IntegenX. “He has excellent capabilities to focus on developing and executing global commercial strategies for the RapidHIT 200.”

“IntegenX is uniquely positioned to capitalize on the widespread adoption of rapid human DNA identification technologies by the public safety and defense communities,” said Mr. Barrett. “IntegenX’s RapidHIT system will provide local law enforcement the ability to secure fast positive identification of criminals and will give homeland security and military forces around the globe new tools to identify persons of interest.”

{ 0 comments }

Pleasanton, California – IntegenX Inc. today announced the launch of mygentegra.com, an e-commerce and information web site for researchers concerned about the economic and environmental costs of traditional freezer-based DNA and RNA sample storage. Researchers exploring current concepts and technologies for nucleic acid storage will find peer-reviewed publications, academic posters, videos, and technical information on GenTegra™ products for long-term, room-temperature DNA and RNA storage and recovery.

While significant advances in high-throughput sequencing have been made in recent years, technologies for sample storage and transport have not enjoyed the same breakthroughs. As a result, sample quality and availability are often the major bottlenecks for these systems. IntegenX provides GenTegra DNA and GenTegra RNA as chemical matrices that protect samples from hydrolysis, oxidation, and microbial destruction. Further, the GenTegra products allow scientists to dry, transport, and store their samples safely at convenient temperatures, including room temperature.

As a convenience to new and returning GenTegra product customers, IntegenX offers on-line purchasing on the mygentegra.com site. Customers can place credit card orders for GenTegra DNA and GenTegra RNA kits, tubes, and accessories.

The first 500 visitors to the mygentegra.com web site will be offered the opportunity to request a free sample of a GenTegra RNA or GenTegra DNA nucleic acid storage vial and reagent. Regarding this offer, IntegenX executive vice president Howard Goldstein said, “Room temperature storage of DNA and RNA is a relatively new concept in nucleic acid research that rarely appears in the legacy cloning manuals used by many labs. The limited free sample program is a way to give interested labs an opportunity to validate how they can safely transport DNA or RNA samples at room temperature, save money on freezer storage, and reduce their carbon footprint.”

{ 0 comments }

INTEGENX RAISES $40 MILLION FINANCING TO SPEED COMMERCIALIZATION OF RAPID HUMAN DNA IDENTIFICATION SYSTEM

RapidHIT™ 200 to Create New Market for Real-time DNA Identification Pleasanton, California – December 13, 2011 – IntegenX Inc., the leading developer of rapid human DNA identification technology and DNA sequencing library preparation systems, has secured $40 Million in Series C funding to accelerate development of the company’s product pipeline and the commercialization of its [...]

Read the full article →

Northrop Grumman Wins Contract Award and Collaborates with IntegenX to Develop Rapid DNA Biometrics Capability

Fast DNA Analysis Yields Tactical Advantage in the Field McLean, VA – September 27, 2011 – Northrop Grumman Corporation announced today that it has been awarded a contract from the U.S. Army BOSS-U (Biometrics Operations and Support Services – Unrestricted) program to further develop and supply the IntegenX RapidHIT™ 200 Human DNA Identification System. Previously, [...]

Read the full article →

INTEGENX AND PROMEGA INK RAPIDHIT™ HUMAN IDENTIFICATION SYSTEM REAGENT SUPPLY AGREEMENT

IntegenX Inc. and Promega Corporation today announced that commercial deliveries of RapidHIT™ 200 Human Identification Systems will include Promega’s nucleic acid purification and short tandem repeat (STR) amplification reagents. Promega’s established STR chemistry will enable users of the automated, self-contained RapidHIT System to produce DNA profiles for human identification from mouth swabs and other human [...]

Read the full article →

INTEGENX ANNOUNCES EARLY ACCESS PARTNERSHIP FOR ITS RAPIDHIT™ 200 HUMAN DNA IDENTIFICATION SYSTEM

Key Forensic Services Ltd Will Be First To Provide Fast DNA Identification To UK Criminal Justice Organizations Pleasanton, California, USA and Coventry, UK – IntegenX Inc. (IXI) today announced an Early Access Program for its RapidHIT™ 200 Human Identification System. The Early Access program is designed to provide IXI’s global partners with advance product access [...]

Read the full article →

INTEGENX PROVES RAPID HUMAN DNA IDENTIFICATION UTILITY AT DOD EXERCISE

Fast DNA Analysis Yields Tactical Advantage in the Field IntegenX Inc. (IXI) disclosed today that the company’s RapidHIT™ 200 Human DNA Identification System repeatedly delivered correct identifications in less than two hours during simulated operational scenarios conducted by the US Department of Defense (DOD). Engineers and technicians from several companies participated in a two-week DOD [...]

Read the full article →

IntegenX, NuGEN Announce Collaboration to Automate the NuGEN Next-Generation Sequencing (NGS) Sample Preparation Workflows

Assays Optimized on the Apollo 324 System Eliminate Manual Sample Processing Bottlenecks, Significantly Increasing Throughput IntegenX Inc. and NuGEN Technologies, Inc. announced today a partnership to automate NuGEN’s NGS Sample Preparation workflows on IntegenX’s Apollo series next-generation sequencing library preparation instruments. NuGEN’s Ovation® RNA-Seq System is the first kit to be automated under this agreement. [...]

Read the full article →

Frost & Sullivan Award Highlights Environmentally Responsible Genetic Analysis Technology at IntegenX Inc.

Energy Requirements for DNA, RNA Preservation and Storage Slashed to Near Zero San Francisco, CA March 16, 2011 – IntegenX Inc. was honored with the Frost & Sullivan Award for Innovation and Leadership at the 2011 Excellence in Life Sciences Awards Banquet in San Francisco, CA. The award recognizes IntegenX’s integration of ambient-temperature biological sample [...]

Read the full article →

Dennis Harris, PhD, Joins IntegenX Inc. as Chief Scientific Officer

March 01, 2011 IntegenX today announced that Dennis Harris, PhD, a leader in the field of biotechnology science innovation, has been appointed as Chief Scientific Officer (CSO). As CSO, Dr. Harris will lead the technology development program at IntegenX and direct the company’s scientific research, collaborations, and grants and contracts strategies. Dr. Harris is a [...]

Read the full article →